Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 20.64 |
|---|---|
| High | 20.89 |
| Low | 18.77 |
| Bid | 19.04 |
| Offer | 20.05 |
| Previous close | 20.85 |
| Average volume | 1.85m |
|---|---|
| Shares outstanding | 282.15m |
| Free float | 145.41m |
| P/E (TTM) | -- |
| Market cap | 5.88bn USD |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Feb 20 2026 21:00 GMT.
More ▼
- Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
- Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan
- Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
- Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect
- Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
- Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
- Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
- The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute
More ▼
